9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy

      research-article
      , MD , , MBBS, MPH, , MD, , MD, , MD, , MD, , BA, PhD, MBA, , MBChB, MD, , MD, MS, , MD, , MD, , MBBS, PhD, , MD, , MD, , MD, , MBBCh, , MD, MS, , MD, , MD, MPH, , MD, PhD, , MD, , MD, , MD, , MD, , MD, , MD, , MD
      Circulation
      Lippincott Williams & Wilkins
      cardiomyopathy, hypertrophic, death, sudden, cardiac, defibrillators, implantable, exercise test, pediatrics

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Background:

          Hypertrophic cardiomyopathy (HCM) can be associated with an abnormal exercise response. In adults with HCM, abnormal results on exercise stress testing are predictive of heart failure outcomes. Our goal was to determine whether an abnormal exercise response is associated with adverse outcomes in pediatric patients with HCM.

          Methods:

          In an international cohort study including 20 centers, phenotype-positive patients with primary HCM who were <18 years of age at diagnosis were included. Abnormal exercise response was defined as a blunted blood pressure response and new or worsened ST- or T-wave segment changes or complex ventricular ectopy. Sudden cardiac death (SCD) events were defined as a composite of SCD and aborted sudden cardiac arrest. Using Kaplan-Meier survival, competing outcomes, and Cox regression analyses, we analyzed the association of abnormal exercise test results with transplant and SCD event-free survival.

          Results:

          Of 724 eligible patients, 630 underwent at least 1 exercise test. There were no major differences in clinical characteristics between those with or without an exercise test. The median age at exercise testing was 13.8 years (interquartile range, 4.7 years); 78% were male and 39% were receiving beta-blockers. A total of 175 (28%) had abnormal test results. Patients with abnormal test results had more severe septal hypertrophy, higher left atrial diameter z scores, higher resting left ventricular outflow tract gradient, and higher frequency of myectomy compared with participants with normal test results ( P<0.05). Compared with normal test results, abnormal test results were independently associated with lower 5-year transplant-free survival (97% versus 88%, respectively; P=0.005). Patients with exercise-induced ischemia were most likely to experience all-cause death or transplant (hazard ratio, 4.86 [95% CI, 1.69–13.99]), followed by those with an abnormal blood pressure response (hazard ratio, 3.19 [95% CI, 1.32–7.71]). Exercise-induced ischemia was also independently associated with lower SCD event-free survival (hazard ratio, 3.32 [95% CI, 1.27–8.70]). Exercise-induced ectopy was not associated with survival.

          Conclusions:

          Exercise abnormalities are common in childhood HCM. An abnormal exercise test result was independently associated with lower transplant-free survival, especially in those with an ischemic or abnormal blood pressure response with exercise. Exercise-induced ischemia was also independently associated with SCD events. These findings argue for routine exercise testing in childhood HCM as part of ongoing risk assessment.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: not found
          • Article: not found

          2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

            Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in the young, although not all patients eligible for sudden death prevention with an implantable cardioverter-defibrillator are identified. Contrast-enhanced cardiovascular magnetic resonance with late gadolinium enhancement (LGE) has emerged as an in vivo marker of myocardial fibrosis, although its role in stratifying sudden death risk in subgroups of HCM patients remains incompletely understood. We assessed the relation between LGE and cardiovascular outcomes in 1293 HCM patients referred for cardiovascular magnetic resonance and followed up for a median of 3.3 years. Sudden cardiac death (SCD) events (including appropriate defibrillator interventions) occurred in 37 patients (3%). A continuous relationship was evident between LGE by percent left ventricular mass and SCD event risk in HCM patients (P=0.001). Extent of LGE was associated with an increased risk of SCD events (adjusted hazard ratio, 1.46/10% increase in LGE; P=0.002), even after adjustment for other relevant disease variables. LGE of ≥15% of LV mass demonstrated a 2-fold increase in SCD event risk in those patients otherwise considered to be at lower risk, with an estimated likelihood for SCD events of 6% at 5 years. Performance of the SCD event risk model was enhanced by LGE (net reclassification index, 12.9%; 95% confidence interval, 0.3-38.3). Absence of LGE was associated with lower risk for SCD events (adjusted hazard ratio, 0.39; P=0.02). Extent of LGE also predicted the development of end-stage HCM with systolic dysfunction (adjusted hazard ratio, 1.80/10% increase in LGE; P<0.03). Extensive LGE measured by quantitative contrast enhanced CMR provides additional information for assessing SCD event risk among HCM patients, particularly patients otherwise judged to be at low risk. © 2014 American Heart Association, Inc.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.

              The aims of this study included performing a meta-analysis of the predictive value of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) for adverse events and death in hypertrophic cardiomyopathy (HCM).
                Bookmark

                Author and article information

                Contributors
                Journal
                Circulation
                Circulation
                CIR
                Circulation
                Lippincott Williams & Wilkins (Hagerstown, MD )
                0009-7322
                1524-4539
                06 November 2022
                28 February 2023
                : 147
                : 9
                : 718-727
                Affiliations
                [1]Department of Pediatrics, Stollery Children’s Hospital, Edmonton, Canada (J.C.).
                [2]Genetics and Genome Biology, Hospital for Sick Children, Toronto, Canada (S. Min, S. Mital).
                [3]Department of Pediatrics, Cincinnati Children’s Hospital, OH (C.V.).
                [4]Department of Cardiology, The Royal Children’s Hospital, Melbourne, Australia (R.G.W.).
                [5]Department of Pediatrics, Children’s Hospital Colorado, Aurora (S.N.).
                [6]Department of Pediatrics, Monroe Carrell Jr Children’s Hospital at Vanderbilt, Nashville, TN (J.G.).
                [7]Ted Rogers Computational Program, Peter Munk Cardiac Centre, University Health Network, Toronto, Canada (M.T.).
                [8]Department of Pediatrics, BC Children’s Hospital, Vancouver, British Columbia, Canada (K.A.).
                [9]Department of Pediatrics, Morgan Stanley Children’s Hospital, Columbia University Medical Centre, New York, NY (M.R.).
                [10]Department of Pediatrics, Lucile Packard Children’s Hospital, Stanford University, Palo Alto, CA (B.K.)
                [11]Department of Pediatrics, Primary Children’s Hospital, University of Utah, Salt Lake City (A.K.L.).
                [12]Department of Pediatrics, Oregon Health and Science University, Portland (S.B.).
                [13]Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX (A.P., N.B.H.).
                [14]Department of Pediatrics, Children’s Hospital of Eastern Ontario, Ottawa, Canada (L.G.).
                [15]Department of Pediatrics, Children’s Hospital of Los Angeles, CA (P.F.K.).
                [16]Department of Pediatrics, Riley Children’s Hospital, Indianapolis, IN (J.J.P.).
                [17]Department of Pediatrics, Cleveland Clinic Children’s Hospital, OH (P.F.A.).
                [18]Department of Pediatrics, University of Tennessee Health Sciences Centre, Memphis (J.L.J.).
                [19]Department of Pediatrics, Hospital for Sick Children, University of Toronto, Canada (A.D., A.J., L.B., S. Mital).
                [20]Department of Pediatrics, University of Michigan Health System, Ann Arbor (M.W.R.).
                [21]Department of Pediatrics, Children’s Healthcare of Atlanta, GA (R.W.).
                [22]Department of Pediatrics, Children’s Hospital of Philadelphia, PA (J.R.).
                [23]Department of Pediatrics, Texas Children’s Hospital, Houston (T.H.).
                [24]Ted Rogers Centre for Heart Research, Toronto, Canada (S. Mital).
                Author notes
                Correspondence to: Seema Mital, MD, Hospital for Sick Children, 555 University Ave, Toronto, Ontario M5G 1X8, Canada; Email seema.mital@ 123456sickkids.ca
                Correspondence to: Jennifer Conway, MD, Stollery Children’s Hospital, 8440 112 St NW, Edmonton, Alberta, T6G 2B7, Canada. Email jennifer.conway2@ 123456albertahealthservices.ca
                Author information
                https://orcid.org/0000-0003-4051-2185
                https://orcid.org/0000-0003-0544-3102
                https://orcid.org/0000-0002-8195-0694
                https://orcid.org/0000-0001-7324-8697
                https://orcid.org/0000-0002-7068-0625
                https://orcid.org/0000-0003-0391-2497
                https://orcid.org/0000-0001-5491-8085
                https://orcid.org/0000-0003-0935-6858
                https://orcid.org/0000-0003-0679-908X
                https://orcid.org/0000-0002-4244-1563
                https://orcid.org/0000-0003-2909-3522
                https://orcid.org/0000-0001-5971-5471
                https://orcid.org/0000-0002-4046-2352
                https://orcid.org/0000-0002-1407-1825
                https://orcid.org/0000-0003-4855-9260
                https://orcid.org/0000-0002-3810-7132
                https://orcid.org/0000-0002-8284-0673
                https://orcid.org/0000-0003-3221-2000
                https://orcid.org/0000-0002-7643-4484
                Article
                00005
                10.1161/CIRCULATIONAHA.122.062699
                9977414
                36335467
                3247297d-a986-451d-88bc-ea86f46cf1fd
                © 2023 The Authors.

                Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.

                History
                : 7 October 2022
                : 3 November 2022
                Categories
                10090
                10095
                Original Research Articles
                Custom metadata
                TRUE
                T

                cardiomyopathy, hypertrophic,death, sudden, cardiac,defibrillators, implantable,exercise test,pediatrics

                Comments

                Comment on this article